Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Catalyst Crew Technologies Corp. entered into an asset purchase agreement with Kevin Rodan Levy, an individual seller and a related party to the company. The buyer will acquire all assets relating to an artificial intelligence-enabled healthcare analytics system (the AI Healthcare Platform) and a technology-enabled healthcare services coordination platform (the Healthcare Services Platform), including related intellectual property.
The agreement provides that the buyer will not assume liabilities of the seller or the assets except as expressly set forth in a written instrument at closing, while the seller retains responsibility for liabilities arising prior to closing, including taxes, contractual obligations, employment-related obligations, and regulatory liabilities. The purchase consideration includes the issuance of 12,000,000 restricted shares of Catalyst Crew Technologies to the seller.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Quvara Medical→Becton Dickinson
Apr 15, 2026
Parkview Health→Witham Health Services
Apr 15, 2026
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra→Oxipit
Apr 15, 2026